The investigation of these mechanisms has led us to further move toward understanding the role of metformin’s protective actions, for example, inhibiting HGP and cancers, anti-obesity, improving complications of COVID-19 and Down syndrome, cardioprotection and neuroprotection. Here, SLC25A16 is linked to obesity due to melanocortin 4 receptor deficiency.